TELA BIO, INC.

Profile

Company Names

TELA BIO, INC.

Addresses

1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA 19355

1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA 19355

1998 ROCHAMBEAU DRIVE, MALVERN, PA 19355

Phone Numbers

484-320-2930
4843202930
610-407-5229

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$104,840,316.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2019-06-28 
$10,623,181.00 
$20,000,000.00 
$9,376,819.00 
Equity 
11
2018-11-20 
$2,067,080.00 
$3,500,000.00 
$1,432,920.00 
Equity 
10
2018-04-30 
$501,120.00 
$2,000,000.00 
$1,498,880.00 
Equity 
9
2018-04-26 
$240,000.00 
$240,000.00 
$0.00 
 
8
2018-04-13 
$500,000.00 
$500,000.00 
$0.00 
Equity 
7
2018-03-23 
$500,000.00 
$1,000,000.00 
$500,000.00 
Equity 
6
2017-10-23 
$15,000,000.00 
$25,000,000.00 
$10,000,000.00 
Equity 
5
2017-01-18 
$7,386,295.00 
$7,500,000.00 
$113,705.00 
Equity 
4
2014-11-20 
$500,000.00 
$500,000.00 
$0.00 
Equity 
3
2014-10-02 
$45,370,140.00 
$45,370,140.00 
$0.00 
Equity 
2
2013-08-13 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
1
2012-12-03 
$16,152,500.00 
$16,152,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KURT 
 
ARARBARZIN 
DIRECTOR
CHRISTINE 
 
ARASIN 
EXECUTIVE OFFICER
KURT 
 
AZARBARZIN 
DIRECTOR
NORA 
 
BRENNAN 
EXECUTIVE OFFICER
VINCE 
 
BURGASS 
DIRECTOR
VINCE 
 
BURGESS 
DIRECTOR
FRANCIS 
 
CONWAY 
EXECUTIVE OFFICER
RONALD 
J. 
ELLIS JR. 
DIRECTOR
RONALD 
J. 
ELLIS, JR. 
DIRECTOR
ASHLEY 
 
FREIDMAN 
DIRECTOR
ANTONY 
 
KOBLISH 
DIRECTOR, EXECUTIVE OFFICER
MAARTEN 
 
PERSENAIRE 
EXECUTIVE OFFICER
CHRISTOPER 
 
SMITH 
EXECUTIVE OFFICER
PAUL 
 
TOUHEY 
DIRECTOR
MATT 
 
ZUGA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2018-04-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-02 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-13 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#